| CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
PPP1R2 |
PPP1R2, IPP2: Protein phosphatase inhibitor 2 |
1.172 |
Evidence |
|
| H2BFS |
H2BFS: Histone H2B type F-S |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
| HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
1.172 |
Evidence |
|
| H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
1.172 |
Evidence |
|
| HIST1H2BJ |
HIST1H2BJ, H2BFR: Histone H2B type 1-J |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
| DUSP14 |
DUSP14, MKP6: Dual specificity protein phosphatase 14 |
CLK3 |
CLK3: Dual specificity protein kinase CLK3 |
1.172 |
Evidence |
|
| HIST1H2BK |
HIST1H2BK, H2BFT, HIRIP1: Histone H2B type 1-K |
WDR48 |
WDR48, KIAA1449: WD repeat-containing protein 48 |
1.172 |
Evidence |
|
| CYP2C18 |
CYP2C18: Cytochrome P450 2C18 |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
1.17 |
Evidence |
|
| CYP2B6 |
CYP2B6: Cytochrome P450 2B6 |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
1.17 |
Evidence |
|
| SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
1.17 |
Evidence |
|
| CSPG4 |
CSPG4, MCSP: Chondroitin sulfate proteoglycan 4 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.17 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
TJP2 |
IPI00216245 |
1.17 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
GRIN1 |
GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor |
1.17 |
Evidence |
|
| TNNI2 |
TNNI2: Troponin I, fast skeletal muscle |
DLG1 |
IPI00218729 |
1.17 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
NKX2-5 |
NKX2-5, CSX, NKX2.5, NKX2E: Homeobox protein Nkx-2.5 |
1.17 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
1.17 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
1.17 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
1.17 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
GMIP |
GMIP: GEM-interacting protein |
1.17 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.17 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
1.17 |
Evidence |
|
| MYF5 |
MYF5: Myogenic factor 5 |
YWHAE |
YWHAE: 14-3-3 protein epsilon |
1.17 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
1.17 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
1.17 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
TAGLN |
TAGLN, SM22, WS3-10: Transgelin |
1.17 |
Evidence |
|